financetom
IRS
financetom
/
Industrials
/
IRS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
IRSA Inversiones y Representaciones SAIRS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

IRSA Inversiones y Representaciones Sociedad Anónima, together with its subsidiaries, engages in the diversified real estate activities in Argentina.

It operates through five segments: Shopping Malls, Offices, Hotels, Sales and Developments, and Others.

The company is involved in the acquisition, development, and operation of shopping malls, office buildings, and other non-shopping mall properties primarily for rental purposes.

It also acquires and operates luxury hotels and resorts under the Intercontinental, Libertador, and Llao Llao names; develops and sells residential properties, including apartment tower complexes; and acquires undeveloped land reserves for future development or sale.

In addition, the company engages in the development and operation of stadium; and provision of ¡appa!, a digital customer loyalty system platform, for consumption in shopping malls, use of parking spaces, and redemption of corporate benefits.

The company was incorporated in 1943 and is headquartered in Buenos Aires, Argentina. IRSA Inversiones y Representaciones Sociedad Anónima operates as a subsidiary of Cresud S.A.C.I.F.

y A.

Latest News >
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
(Reuters) -U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. We are all in ... we are building our teams ... We are recruiting experts in obesity over the last, let's...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday. ...
Sector Update: Tech
Sector Update: Tech
Jan 13, 2025
01:44 PM EST, 01/13/2025 (MT Newswires) -- Tech stocks declined Monday afternoon with the Technology Select Sector SPDR Fund (XLK) falling 1.1% and the SPDR S&P Semiconductor ETF (XSD) dropping 1.4%. The Philadelphia Semiconductor index shed 0.8%. In corporate news, Clearwater Analytics ( CWAN ) agreed to buy Enfusion ( ENFN ) for $1.5 billion in cash and stock. Enfusion...
Looking At McDonald's's Recent Unusual Options Activity
Looking At McDonald's's Recent Unusual Options Activity
Jan 13, 2025
Deep-pocketed investors have adopted a bearish approach towards McDonald's , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen. We gleaned this information from our observations today...
Copyright 2023-2025 - www.financetom.com All Rights Reserved